StonvexLoading…
StonvexStonvexStonvexCore line items from DCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.84B | $6.12B | $6.08B | $5.80B |
Operating Income | $112.30M | $241.40M | $146.60M | $243.90M |
Net Income | $-19.70M | $35.00M | $-33.60M | $64.30M |
EPS (Diluted) | $-0.17 | $0.29 | $-0.29 | $0.53 |
Total Assets | $6.67B | $5.06B | $5.36B | $5.47B |
Total Liabilities | $6.03B | $4.50B | $4.75B | $4.84B |
Cash & Equivalents | $708.90M | $552.90M | $519.90M | $511.50M |
Free Cash Flow OCF − CapEx | $155.10M | $207.40M | $201.50M | $277.50M |
Shares Outstanding | 118.70M | 117.60M | 117.10M | 114.60M |